Kidney cancer, Renal cell cancer
Results
Phase 2
This trial compared AZD2014 with everolimus (Afinitor) as a treatment for kidney cancer. It was for people with a type of kidney cancer called clear cell that had spread to another part of the body.
Recruitment start: 5 February 2013
Recruitment end: 12 June 2014
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Thomas Powles
AstraZeneca
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
Queen Mary University of London
This is Cancer Research UK trial number CRUKE/11/037.
Last reviewed: 23 Jun 2014
CRUK internal database number: 8784
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
